News 21 May 2026 - 22 May 2026

Cyngn Shares Eye $1.43 Level as Deployments Go Up, Losses Persist
···

Cyngn Shares Eye $1.43 Level as Deployments Go Up, Losses Persist

Cyngn Inc. shares closed at $1.43 Friday, unchanged for the week and near a 52-week low, ahead of the Memorial Day market closure. First-quarter revenue rose to $104,573 from $47,152 a year earlier, while net loss widened to $6.49 million. Trading volume Friday was about 175,450 shares, below average. The stock recovered from a midweek low of $1.29 but remains thinly traded.
May 24, 2026
WiMi Surges After Quantum AI News, Traders Watch Next Moves
···

WiMi Surges After Quantum AI News, Traders Watch Next Moves

WiMi Hologram Cloud shares closed up 1.86% at $1.64 Thursday after announcing research into a quantum-computing optimization method. Trading volume was 275,550 shares, below average. The update came as quantum stocks rallied on news of a potential $100 million U.S. government investment in D-Wave Quantum. WiMi did not announce any commercial launch or customer deals.
May 22, 2026
Perion stock falls after Q1 miss, AI ad spend soars
···

Perion stock falls after Q1 miss, AI ad spend soars

Perion Network shares fell 1.9% to $8.84 Thursday, extending a 16% drop after first-quarter results missed revenue targets and showed a wider loss. Revenue rose 1% to $90.4 million, while adjusted EBITDA fell to $0.5 million from $1.8 million. Spending on the company’s Outmax AI agent jumped 316% year over year. The stock underperformed rivals as investors questioned profit growth.
May 22, 2026
GPCR Stock Jumps As Obesity-Drug Race Gets A New Twist
···

GPCR Stock Jumps As Obesity-Drug Race Gets A New Twist

Structure Therapeutics shares climbed 5.3% to $38.79 in late New York trading Thursday, with no new company release in the past two days. The move followed Eli Lilly’s report of strong weight-loss data for its obesity drug, which kept focus on the sector. Structure’s aleniglipron showed 16.3% placebo-adjusted mean weight loss at 44 weeks in Phase 2. Monashee Investment Management trimmed its stake in the first quarter, SEC filings show.
May 21, 2026
Abivax Shares On the Move Again As Filing Catches Trader Interest Ahead of June
···

Abivax Shares On the Move Again As Filing Catches Trader Interest Ahead of June

Abivax SA’s Nasdaq-listed shares rose 3.5% to $124.03 Thursday as investors awaited late-Q2 topline data from its Phase 3 trial of obefazimod for ulcerative colitis. A May 20 SEC filing showed shareholders approved capital-raising mandates and a U.S. ATM program with 78.2% support. The company recently repurchased royalty certificates for $90 million, partly in ADSs. Paris shares closed at 105.10 euros, up 2.14%.
May 21, 2026
InterDigital shares up after IoT payments patent agreement
···

InterDigital shares up after IoT payments patent agreement

InterDigital shares edged up to $267.10 in after-hours trading Thursday after announcing a new Internet of Things licensing deal with an unnamed payments-technology company. The agreement covers point-of-sale devices under InterDigital’s global patent portfolio. Annualized recurring revenue rose 13% year-over-year to $567.2 million in the March quarter. Financial terms of the new deal were not disclosed.
May 21, 2026
CHRW Stock Pulls Back After Big Rally. The C.H. Robinson Test Just Got Harder
···

CHRW Stock Pulls Back After Big Rally. The C.H. Robinson Test Just Got Harder

C.H. Robinson Worldwide shares fell 1.5% to $178.13 Thursday, reversing part of a four-day rally, as investors weighed a Wall Street upgrade against new legal risks. The decline came despite broader U.S. stock gains and followed a Supreme Court ruling allowing state negligent-hiring claims against freight brokers. Trading volume reached about 1.6 million shares.
May 21, 2026
PMEC Dips Below $1; Primech Contract Wins Don’t Halt Selloff
···

PMEC Dips Below $1; Primech Contract Wins Don’t Halt Selloff

Primech Holdings shares fell 9% to $0.7001 Thursday, keeping the Singapore-based company’s Nasdaq listing below the $1 minimum bid price. The drop comes despite recent cleaning and robotics contracts, including a $24.8 million airport deal and a three-year robot deployment. Primech has until Aug. 24, 2026, to regain compliance or face possible delisting. Market capitalization stood at about $24.9 million.
May 21, 2026
Veritone shares pop 16% as traders look at small AI firm with funding issues
···

Veritone shares pop 16% as traders look at small AI firm with funding issues

Veritone shares surged 16.3% to $2.28 on Thursday, with trading volume more than doubling from the previous day, despite no new company announcements. The move followed a recent earnings report showing first-quarter revenue down 9.8% to $20.3 million, but annual recurring revenue up 9.4% to $64.2 million. Market value reached about $212 million. The company reaffirmed its 2026 revenue forecast.
May 21, 2026
Why Daily Journal Stock Is Sliding Even After a 25% Revenue Jump
···

Why Daily Journal Stock Is Sliding Even After a 25% Revenue Jump

Daily Journal Corp. shares fell 0.4% to $462.36 in Thursday afternoon Nasdaq trading, extending a two-day slide after reporting a $34.6 million quarterly net loss tied to $51.2 million in unrealized investment losses. Revenue rose 25% to $22.7 million, led by Journal Technologies. Trading volume was about 38,900 shares, with a market value near $637 million. The stock remained below its May 14 close after results were released.
May 21, 2026
Fold Holdings Stock Nears $1 As New SEC Filings Put Share Supply In Focus
···

Fold Holdings Stock Nears $1 As New SEC Filings Put Share Supply In Focus

Fold Holdings shares slipped 0.8% to $1.26 after the company filed new prospectus supplements and reported annual-meeting results. CEO Will Reeves sold 20,362 shares to cover tax withholding, retaining 5.51 million. First-quarter revenue fell 21% to $5.6 million, with a net loss of $29.2 million. Shareholders elected two directors and ratified the auditor for 2026.
May 21, 2026
Atrium Therapeutics Stock Climbs: The Key FDA Filing Investors Are Watching Now
···

Atrium Therapeutics Stock Climbs: The Key FDA Filing Investors Are Watching Now

Atrium Therapeutics shares climbed 1.9% to $12.96 Thursday, valuing the company at about $222 million. The RNA drug developer expects to submit its first IND for ATR 1072, targeting PRKAG2 syndrome, in the second half of 2026. Atrium reported $267.8 million in cash at March 31, with all programs still preclinical. Leerink Partners initiated coverage last week with an outperform rating and $25 price target.
May 21, 2026
NewtekOne Stock Moves as Investors Watch Digital Bank Pivot
···

NewtekOne Stock Moves as Investors Watch Digital Bank Pivot

NewtekOne Inc. shares rose 1.1% to $13.40 Thursday after first-quarter earnings met 2026 guidance and deposits nearly doubled to $1.9 billion from a year earlier. The company reported EPS of $0.43, up from $0.36 last year. Loan production reached $391 million for the quarter. CEO Barry Sloane cited credit quality as a key concern on the earnings call.
May 21, 2026
1 … 8 9 10 11 12 … 341

Stock Market Today

  • ASX Futures Dip as Wall Street Climbs, Iran Diplomacy Hopes Weigh on Oil Prices
    May 24, 2026, 5:39 PM EDT. Before the Australian Securities Exchange (ASX) opens on May 25, 2026, S&P/ASX 200 futures indicate a 0.65% decline following a 1% gain last week. On Wall Street, stocks rose with the Dow Jones up 0.58%, S&P 500 0.37%, and Nasdaq 0.19%, marking the S&P 500's longest winning streak since 2023 at eight weeks. Traders react to geopolitical developments: optimism over a potential U.S.-Iran agreement tempered by Iranian denial. Crude oil prices dropped below $97 a barrel amid diplomacy hopes. U.S. Treasury yields hit a near 16-month high as Federal Reserve signals possible rate hikes. In corporate news, Nvidia reprimanded Super Micro Computer over AI server compliance, Anthropic nears a $900 billion valuation, Zoom raised growth guidance, and Uber explored acquiring Delivery Hero.